M&A Deal Summary

Noramco Acquires Cambrex Drug Product- Business Unit

On November 2, 2023, Noramco acquired healthcare services company Cambrex Drug Product- Business Unit from Cambrex

Acquisition Highlights
  • This is Noramco’s 1st transaction in the Healthcare Services sector.
  • This is Noramco’s 1st transaction in the United States.
  • This is Noramco’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2023-11-02
Target Cambrex Drug Product- Business Unit
Sector Healthcare Services
Buyer(s) Noramco
Sellers(s) Cambrex
Deal Type Divestiture

Target

Cambrex Drug Product- Business Unit

Whippany, New Jersey, United States
Cambrex Drug Product's Business Unit is a technology-focused contract manufacturing business with differentiated applications and capabilities in solid, semi-solid and liquid dosage forms, with a particular focus on controlled substances. Cambrex Drug Product's Business Unit was established in 2006 and is based in Whippany, New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Noramco

Wilmington, Delaware, United States
Category Company
Founded 1979
Sector Life Science
DESCRIPTION

Noramco is a provider in the production of controlled substances for the pharmaceutical industry, for medicines used to treat Attention Deficit Hyperactivity Disorder, pain, addiction, and for abuse-deterrent formulations. Noramco was founded in 1979 and is based in Wilmington, Delaware.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1

Seller(S) 1

SELLER

Cambrex

East Rutherford, New Jersey, United States
Category Company
Founded 1981
Sector Life Science
Employees1,228
Revenue 534M USD (2017)
DESCRIPTION

Cambrex is a life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapeutics. Cambrex was formed in 1981 and is headquartered in East Rutherford, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-21 Snapdragon Chemistry

Waltham, Massachusetts, United States

Snapdragon Chemistry designs practical manufacturing solutions for challenging chemical processes. The company also designs technologies that enable efficient design and development of chemical processes with enhanced process understanding. It has partnered with clients from around the globe, from Fortune 100 to leading-edge startup companies, to deliver efficient, cost-effective, and robust solutions for fine chemical and pharmaceutical manufacturing. Snapdragon Chemistry was formed in 2014 and is headquartered in Waltham, Massachusetts.

Buy -
Mergr

Product

Company

Legal